Colgate-Palmolive Co.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.36B | $5.32B | $5.23B | $5.13B | $5.11B | $4.91B | $4.95B | $5.03B |
| Cost of Revenue | $2.07B | $2.10B | $2.08B | $2.08B | $2.04B | $1.92B | $1.96B | $1.96B |
| Gross Profit | $3.30B | $3.23B | $3.15B | $3.05B | $3.07B | $2.99B | $2.98B | $3.07B |
| Gross Margin | 61.5% | 60.6% | 60.2% | 59.4% | 60.1% | 60.8% | 60.3% | 61.1% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.13B | $2.08B | $2.07B | $1.97B | $1.96B | $1.90B | $1.90B | $1.98B |
| Operating Income | $1.02B | $964.0M | $91.0M | $1.06B | $1.08B | $1.08B | $1.06B | $1.07B |
| Operating Margin | 19.0% | 18.1% | 1.7% | 20.6% | 21.1% | 21.9% | 21.5% | 21.2% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $950.0M | $892.0M | $107.0M | $992.0M | $1.01B | $953.0M | $993.0M | $986.0M |
| Income Tax Expense | $231.0M | $211.0M | $111.0M | $226.0M | $234.0M | $227.0M | $216.0M | $210.0M |
| Net Income | $693.0M | $646.0M | $-36.0M | $735.0M | $743.0M | $690.0M | $738.0M | $737.0M |
| Net Margin | 12.9% | 12.1% | -0.7% | 14.3% | 14.5% | 14.1% | 14.9% | 14.6% |
| EPS (Basic) | $0.87 | $0.81 | $-0.04 | $0.91 | $0.92 | $0.85 | $0.91 | $0.90 |
| EPS (Diluted) | $0.86 | $0.80 | $-0.04 | $0.91 | $0.91 | $0.85 | $0.89 | $0.90 |
| Shares Outstanding (Basic) | 799.4M | 802.3M | 808.7M | 807.8M | 810.2M | 812.0M | 819.1M | 817.7M |
| Shares Outstanding (Diluted) | 801.8M | 805.1M | 811.1M | 810.2M | 813.3M | 815.0M | 823.2M | 822.5M |
| Dividends Per Share | $0.53 | $0.53 | $0.52 | $0.52 | $0.52 | $0.52 | $0.50 | $0.50 |